Patient Adjudication protocol. Correct patient adjudication is essential for any patient-oriented studies in human subject. Both biobanks have implemented mechanisms to ensure the accuracy of the research data associated with each specimen. These mechanisms are shared among the different institutions and are re-evaluated for improvement regularly. The valvular pathologies, with regards to the morphology of the valve, presence of calcium nodule thickening of the cusps, the degree of stenosis, and the etiology of the disease are assessed at the time of collection by the operating surgeon, via the echocardiographic reports at the Heart Transplant program and transcribed by the study staff from the original operative report or dictation into the research database. This is retrospectively re-assessed by cross-matching the entry in the biobank registry with the diagnosis entered in the pre-operative echocardiogram report as well as any ancillary imaging (e.g. CT scan, MRI). Any inconsistencies is adjudicated by the patient's operating surgeon or a qualified physician associated with the biobank. This adjudication includes a review of the operative report, pre-and peri-operative diagnostic imaging, and, where necessary, review of pathology reports. Clinical data, including pertinent medical history and comorbidities are extracted from the source (i.e. original hospital chart) and entered into the research database by trained study personnel, with regular auditing for quality and accuracy by the personnel involved using the patient's original medical record.
RT2
Profile PCR Array and RT-qPCR RNA was quantified using Nano drop and used for two step PCR amplification. 2 ug total RNA was converted into cDNA. cDNA was analyzed with the RT2 Profiler PCR Array for the detection of the expression of 84 human extracellular matrix and adhesion molecules. Real Time PCR (RT-qPCR) was performed on ABI Prism 7500 HT (Applied Biosystems, Carlsbad, CA), according to the manufacturer's instructions. Data analysis was performed using the web based qPCR data analysis software provided by SABiosciences. Validation of genes from PCR array was carried out by RT-qPCR using gene specific primers (OPN Fw 5'-TTG CAG CCT TCT CAG CCA A -3', Rv 5'-GGA GGC AAA AGC AAA TCA CTG -3'; THBS1 Fw 5'-CAC AGC TCG TAG AAC AGG AGG -3', Rv 5'-CAA TGC CAC AGT TCC TGA TG -3'; THBS2 Fw 5'-GCA GCG TCT CTG TGT TCT CA -3', Rv 5'-GAG TCA CTT CAG GGG TTT CG -3'; SMA Fw 5'-TTT TCC CAT CCA TTG TGG GAC-3', Rv 5'-TCC CAT TCC CAC CAT CAC C-3'; Cyr61 Fw 5'-CCC GTT TTG GTA GAT TCT GG-3', Rv 5'-GCT GGA ATG CAA CTT CGG-3'; SPARC Fw 5'-GAG AAA GAA GAT CCA GGC CC-3'; 18S Fw5'-GTAACC CGT TGA ACC CCA TT-3', Rv 5'-CCA TCC AAT CGG TAG TAG CG-3'. Dissociation curves were generated after each run to control formation of primer dimers. 18S gene expression was used for normalization. Normalization of each data point was carried out, in which dCt = Ct(test gene) -Ct(18S); ddCt = dCt(test sample) -dCt(18S control).
Histological analysis. Aortic valve tissues, Controls, Aortic valve Sclerotic (AVSc) and Aortic Valve Stenosis (AVS) were fixed in 10% Formalin and paraffin embedded. Hematoxylin & Eosin, Alizarin Red staining (for calcium) and Picrosirius Red (for collagen I and III fibers) were performed on 6µm sections by the Pathology Core of Children's Hospital of Philadelphia; Hematoxylin and Eosin (H&E), Alizarin Red staining (for calcium) was performed according to the protocol of the Histology Laboratory of the University Of Pennsylvania Perelman School of
